Do NOBORI biolimus-eluting stents improve clinical outcomes compared to XIENCE/PROMUS everolimus-eluting stents in patients with small vessel disease?
Biolimus-eluting stents show similar two-year clinical outcomes to everolimus-eluting stents in small coronary artery disease, supporting their use in this population.
Two-year clinical outcomes of BES are similar to those of CoCr-EES in patients with small vessel disease. The use of BES is acceptable for small coronary artery disease. © 2015 Wiley Periodicals, Inc.
Jinnouchi et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: